Mesa Exploration Corp. (the ‘company’ or ‘Mesa’) announced that it has signed a non-binding letter of intent with THOR Pharma to acquire all of the issued and outstanding common shares of THOR, an applicant under Health Canada's ‘Access to Cannabis for Medical Purposes Regulations’. The current directors of THOR are Don Shaxon and Jason Springett. THOR will be reconstituting its Board prior to the closing of the contemplated transaction. It is expected that Foster Wilson will continue with the company in the capacity of Director but that, effective the closing of the contemplated transaction, all other current directors and officers of Mesa will resign.